208 related articles for article (PubMed ID: 12181283)
1. Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells.
Hiruma H; Saito A; Kusakabe T; Takenaka T; Kawakami T
J Physiol; 2002 Aug; 543(Pt 1):85-97. PubMed ID: 12181283
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E(2) enhances axonal transport and neuritogenesis in cultured mouse dorsal root ganglion neurons.
Hiruma H; Ichikawa T; Kobayashi H; Hoka S; Takenaka T; Kawakami T
Neuroscience; 2000; 100(4):885-91. PubMed ID: 11036222
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of histamine on axonal transport in cultured mouse dorsal root ganglion neurons.
Amano R; Hiruma H; Nishida S; Kawakami T; Shimizu K
Neurosci Res; 2001 Oct; 41(2):201-6. PubMed ID: 11591447
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.
Gibbs J; Flores CM; Hargreaves KM
Neuroscience; 2004; 125(3):703-9. PubMed ID: 15099684
[TBL] [Abstract][Full Text] [Related]
5. Low-concentration lidocaine rapidly inhibits axonal transport in cultured mouse dorsal root ganglion neurons.
Kanai A; Hiruma H; Katakura T; Sase S; Kawakami T; Hoka S
Anesthesiology; 2001 Sep; 95(3):675-80. PubMed ID: 11575541
[TBL] [Abstract][Full Text] [Related]
6. Effects of substance P and calcitonin gene-related peptide on axonal transport in isolated and cultured adult mouse dorsal root ganglion neurons.
Hiruma H; Saito A; Ichikawa T; Kiriyama Y; Hoka S; Kusakabe T; Kobayashi H; Kawakami T
Brain Res; 2000 Nov; 883(2):184-91. PubMed ID: 11074047
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
McDonald RL; Vaughan PF; Beck-Sickinger AG; Peers C
Neuropharmacology; 1995 Nov; 34(11):1507-14. PubMed ID: 8606797
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y inhibits the hyperexcitability of type A neurons in chronically compressed dorsal root ganglion of the rat.
Xu H; Tong Y; Zhang X; Jiao X; Hu S
Neurosci Lett; 2002 Apr; 323(1):70-4. PubMed ID: 11911992
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
[TBL] [Abstract][Full Text] [Related]
11. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry.
Landry M; Holmberg K; Zhang X; Hökfelt T
Exp Neurol; 2000 Apr; 162(2):361-84. PubMed ID: 10739642
[TBL] [Abstract][Full Text] [Related]
12. Extracellular potassium rapidly inhibits axonal transport of particles in cultured mouse dorsal root ganglion neurites.
Hiruma H; Nishida S; Katakura T; Kusakabe T; Takenaka T; Kawakami T
J Neurobiol; 1999 Feb; 38(2):225-33. PubMed ID: 10022568
[TBL] [Abstract][Full Text] [Related]
13. The effect of intrathecal selective agonists of Y1 and Y2 neuropeptide Y receptors on the flexor reflex in normal and axotomized rats.
Xu IS; Hao JX; Xu XJ; Hökfelt T; Wiesenfeld-Hallin Z
Brain Res; 1999 Jul; 833(2):251-7. PubMed ID: 10375701
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
Yu XJ; Moskowitz MA
Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
[TBL] [Abstract][Full Text] [Related]
15. Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro.
Martins J; Elvas F; Brudzewsky D; Martins T; Kolomiets B; Tralhão P; Gøtzsche CR; Cavadas C; Castelo-Branco M; Woldbye DP; Picaud S; Santiago AR; Ambrósio AF
ASN Neuro; 2015; 7(4):. PubMed ID: 26311075
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
Besecke LM; Wolfe AM; Pierce ME; Takahashi JS; Levine JE
Endocrinology; 1994 Oct; 135(4):1621-7. PubMed ID: 7925125
[TBL] [Abstract][Full Text] [Related]
17. Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons.
Abdulla FA; Smith PA
Neuroscience; 1999 Mar; 89(1):43-60. PubMed ID: 10051216
[TBL] [Abstract][Full Text] [Related]
18. Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries.
Prieto D; Hernández M; Rivera L; García-Sacristán A; Simonsen U
Regul Pept; 1997 Apr; 69(3):155-65. PubMed ID: 9226400
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.
Hökfelt T; Broberger C; Zhang X; Diez M; Kopp J; Xu Z; Landry M; Bao L; Schalling M; Koistinaho J; DeArmond SJ; Prusiner S; Gong J; Walsh JH
Brain Res Brain Res Rev; 1998 May; 26(2-3):154-66. PubMed ID: 9651513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
